2 Firms To Lead Investor Suit Over Myovant-Sumitomo Deal
By Katryna Perera · October 11, 2023, 2:43 PM EDT
Two firms have been named lead counsel for a proposed class action against Myovant Sciences Ltd. and Sumitomo Pharma America Inc. claiming lawyers from Skadden Arps Slate Meagher & Flom LLP...
To view the full article, register now.